Mirror Trial - Follow-Up Management of Peripheral Arterial Intervention With Clopidogrel

• Status: Completed
• Trial end date: 2011-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The Mirror Study is a randomized, double-blinded mono-centre trial the access the periinterventinal and postinterventional administration of clopidogrel in patients with peripheral vascular disease.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital Tuebingen
• Treatments: Clopidogrel; Ticlopidine

Criteria

Inclusion Criteria:

• Peripheral arterial disease which requires intervention

Exclusion Criteria:

• Patient already on coumadin or clopidogrel

• Acute onset of PVD symptoms

• Patient requiring an operation

• Contraindication to aspirin and clopidogrel